Advertisement

Topics

Solid First-in-Human Results from Vaccine against Birth Defects

05:57 EDT 4 May 2017 | Labiotech.eu

Hookipa has presented positive data from its first Phase I trial testing its vaccine technology against human cytomegalovirus (hCMV) infections. Hookipa, one of the top 10 biotechs we’re closely following this year, is developing a viral vaccine platform that has ...

This awesome article Solid First-in-Human Results from Vaccine against Birth Defects appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Solid First-in-Human Results from Vaccine against Birth Defects

NEXT ARTICLE

More From BioPortfolio on "Solid First-in-Human Results from Vaccine against Birth Defects"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...